NanoSphere Health Sciences Inc. (NSHSF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NanoSphere Health Sciences Inc. (NSHSF) with AI Score 48/100 (Weak). NanoSphere Health Sciences Inc. focuses on delivering biologically active compounds through its NanoSphere Delivery System. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026NanoSphere Health Sciences Inc. (NSHSF) Healthcare & Pipeline Overview
NanoSphere Health Sciences Inc. is a nano-biotechnology company providing biologically active compounds via its proprietary NanoSphere Delivery System. Targeting the cannabis, pharmaceutical, and animal health sectors in the US and Canada, the company aims to improve the bioavailability and effectiveness of supplements, nutraceuticals, and over-the-counter medications.
Investment Thesis
NanoSphere Health Sciences Inc. presents a speculative investment opportunity within the nano-biotechnology sector. The company's NanoSphere Delivery System has potential in the cannabis, pharmaceutical, and animal health industries. A key value driver is the successful commercialization of the NanoSphere Delivery System through partnerships and licensing agreements. Growth catalysts include expanding applications of the technology into new therapeutic areas and securing regulatory approvals for pharmaceutical applications. The company's current P/E ratio is 0.36. However, investors may want to evaluate the risks associated with investing in OTC-listed companies, including limited liquidity and disclosure. As of 2026-03-17, the company's market capitalization is $0.00B, reflecting the early stage and speculative nature of the investment. The beta of 0.77 suggests lower volatility compared to the overall market.
Based on FMP financials and quantitative analysis
Key Highlights
- NanoSphere Delivery System is the core technology, offering potential for enhanced bioavailability of active compounds.
- Targets multiple sectors including cannabis, pharmaceutical, and animal health, diversifying application potential.
- Headquartered in Vancouver, Canada, with operations in the United States and Canada.
- P/E ratio of 0.36 indicates potential value, but requires further investigation due to limited financial data.
- Beta of 0.77 suggests lower volatility compared to the overall market, which may appeal to risk-averse investors.
Competitors & Peers
Strengths
- Proprietary NanoSphere Delivery System.
- Potential for enhanced bioavailability.
- Applications across multiple industries.
- Experienced management team.
Weaknesses
- Limited financial resources.
- Dependence on partnerships for commercialization.
- Early stage of development.
- OTC listing with limited liquidity.
Catalysts
- Upcoming: Potential partnerships with pharmaceutical companies to utilize the NanoSphere Delivery System.
- Upcoming: Regulatory approvals for pharmaceutical applications of the NanoSphere technology.
- Ongoing: Expansion of the NanoSphere Delivery System into new therapeutic areas.
- Ongoing: Development of new product formulations utilizing the NanoSphere technology.
- Ongoing: Geographic expansion into new markets, such as Europe and Asia.
Risks
- Potential: Competition from established drug delivery companies.
- Potential: Regulatory hurdles and compliance requirements.
- Potential: Technological obsolescence of the NanoSphere Delivery System.
- Ongoing: Limited financial resources and dependence on partnerships.
- Ongoing: OTC listing with limited liquidity and transparency.
Growth Opportunities
- Expansion into Pharmaceutical Applications: NanoSphere has the opportunity to extend its NanoSphere Delivery System into the pharmaceutical industry. This involves partnering with pharmaceutical companies to improve the delivery of existing drugs or developing new drug formulations utilizing the NanoSphere technology. The global pharmaceutical market is projected to reach $1.7 trillion by 2027, offering a substantial market for NanoSphere's delivery system. Success in this area hinges on clinical trials demonstrating improved efficacy and safety compared to traditional drug delivery methods. Timeline: Ongoing, with potential for significant revenue generation within 3-5 years pending regulatory approvals.
- Penetration of the Animal Health Market: The animal health market presents another growth avenue for NanoSphere. Applying the NanoSphere Delivery System to animal health products, such as supplements and medications, can improve absorption and effectiveness. The global animal health market is expected to reach $75 billion by 2027. NanoSphere can target specific segments within this market, such as companion animals or livestock. Success depends on demonstrating the benefits of the NanoSphere technology to animal health companies and securing partnerships for product development and distribution. Timeline: Ongoing, with potential for revenue generation within 2-3 years.
- Licensing Agreements and Partnerships: NanoSphere can generate revenue through licensing its NanoSphere Delivery System to other companies in the cannabis, pharmaceutical, and animal health industries. This involves granting companies the right to use the NanoSphere technology in their products in exchange for royalties or licensing fees. This approach allows NanoSphere to leverage its technology without the need for extensive manufacturing and distribution infrastructure. The success of this strategy depends on the attractiveness of the NanoSphere technology to potential licensees and the negotiation of favorable licensing terms. Timeline: Ongoing, with potential for immediate revenue generation upon signing licensing agreements.
- Development of Proprietary Products: NanoSphere can develop and market its own line of products utilizing the NanoSphere Delivery System. This involves formulating supplements, nutraceuticals, or over-the-counter medications with the NanoSphere technology and selling them directly to consumers or through retail channels. This approach allows NanoSphere to capture a larger share of the value chain but requires significant investment in product development, manufacturing, and marketing. The success of this strategy depends on the ability to create innovative and differentiated products that appeal to consumers. Timeline: Ongoing, with potential for revenue generation within 1-2 years.
- Geographic Expansion: NanoSphere currently operates primarily in the United States and Canada. Expanding into new geographic markets, such as Europe and Asia, presents a growth opportunity. This involves adapting the NanoSphere technology to meet the regulatory requirements of different countries and establishing partnerships with local distributors. The global market for drug delivery technologies is growing rapidly, particularly in emerging markets. Success depends on the ability to navigate regulatory complexities and establish a strong presence in new markets. Timeline: Ongoing, with potential for revenue generation within 3-5 years.
Opportunities
- Expansion into new therapeutic areas.
- Securing regulatory approvals for pharmaceutical applications.
- Penetration of the animal health market.
- Geographic expansion into new markets.
Threats
- Competition from established drug delivery companies.
- Regulatory hurdles and compliance requirements.
- Technological obsolescence.
- Economic downturn affecting healthcare spending.
Competitive Advantages
- Proprietary NanoSphere Delivery System technology.
- Potential for enhanced bioavailability compared to traditional delivery methods.
- Applications across multiple industries (cannabis, pharmaceutical, animal health).
- Partnerships and collaborations with established companies.
About NSHSF
NanoSphere Health Sciences Inc., incorporated in 2005 and headquartered in Vancouver, Canada, is a nano-biotechnology company focused on the delivery of biologically active compounds. The company's core technology is the NanoSphere Delivery System, a platform designed to enhance the bioavailability and effectiveness of various substances. This system utilizes nanotechnology to encapsulate and deliver supplements, nutraceuticals, and over-the-counter medications. NanoSphere's initial focus was on the cannabis industry, aiming to provide innovative delivery methods for cannabinoids. Over time, the company has expanded its scope to include the pharmaceutical and animal health industries, exploring applications of its delivery system for a broader range of therapeutic compounds. NanoSphere Health Sciences operates primarily in the United States and Canada, seeking partnerships and collaborations to commercialize its technology across different sectors. The company aims to differentiate itself through its proprietary delivery system, which it believes offers superior absorption and targeted delivery compared to traditional methods. NanoSphere continues to research and develop new applications for its technology, seeking to establish itself as a leader in nano-biotechnology delivery systems.
What They Do
- Develops the NanoSphere Delivery System, a nanotechnology platform.
- Enhances the bioavailability of active compounds.
- Targets the cannabis industry with improved delivery methods for cannabinoids.
- Expands applications to the pharmaceutical industry for drug delivery.
- Applies the technology to the animal health industry for supplements and medications.
- Seeks partnerships and collaborations for commercialization.
- Operates in the United States and Canada.
Business Model
- Licensing the NanoSphere Delivery System to other companies.
- Developing and marketing proprietary products utilizing the NanoSphere technology.
- Partnering with companies in the cannabis, pharmaceutical, and animal health industries.
- Generating revenue through royalties, licensing fees, and product sales.
Industry Context
NanoSphere Health Sciences Inc. operates within the biotechnology industry, specifically focusing on drug delivery systems. The market for drug delivery technologies is experiencing growth, driven by the need for more effective and targeted therapies. The competitive landscape includes companies developing novel delivery methods, such as nanoparticles, liposomes, and other advanced materials. NanoSphere aims to differentiate itself through its proprietary NanoSphere Delivery System. The biotechnology industry is characterized by high research and development costs, regulatory hurdles, and intense competition. NanoSphere's success depends on its ability to secure partnerships, obtain regulatory approvals, and demonstrate the superiority of its technology compared to existing delivery methods.
Key Customers
- Cannabis companies seeking improved delivery methods for cannabinoids.
- Pharmaceutical companies looking to enhance the bioavailability of drugs.
- Animal health companies seeking to improve the effectiveness of supplements and medications.
- Consumers purchasing products utilizing the NanoSphere Delivery System.
Financials
Chart & Info
NanoSphere Health Sciences Inc. (NSHSF) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 2, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Sep 25, 2019
-
Stocks That Fell Through 52-Week Lows Wednesday
· Aug 7, 2019
-
Stocks That Set New 52-Week Lows Friday Morning
· Aug 2, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NSHSF.
Price Targets
Wall Street price target analysis for NSHSF.
MoonshotScore
What does this score mean?
The MoonshotScore rates NSHSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Michael Alexander Iverson
CEO
Michael Alexander Iverson serves as the Chief Executive Officer of NanoSphere Health Sciences Inc. His background includes experience in the healthcare and biotechnology sectors, with a focus on strategic leadership and business development. Iverson's expertise lies in guiding companies through growth phases, securing partnerships, and navigating the regulatory landscape. He has a track record of driving innovation and commercializing new technologies. His leadership is focused on expanding the applications of the NanoSphere Delivery System and building shareholder value.
Track Record: Under Michael Alexander Iverson's leadership, NanoSphere Health Sciences Inc. has focused on expanding the applications of its NanoSphere Delivery System into new markets, including pharmaceuticals and animal health. He has overseen the development of new product formulations and the pursuit of strategic partnerships. A key achievement has been securing collaborations with companies in various sectors to commercialize the NanoSphere technology. His tenure has been marked by efforts to enhance the company's visibility and attract investment.
NSHSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that NanoSphere Health Sciences Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity can be sporadic. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to the same stringent listing standards, leading to increased risks for investors. This tier often includes companies with limited operating history, distressed financials, or those that are thinly traded.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC Other listing.
- Lack of transparency and potential for incomplete financial disclosures.
- Higher price volatility compared to exchange-listed stocks.
- Potential for price manipulation due to thin trading volume.
- Increased risk of fraud or mismanagement due to less stringent regulatory oversight.
- Verify the company's financial statements and audit reports.
- Assess the management team's experience and track record.
- Review the company's business plan and growth strategy.
- Evaluate the competitive landscape and NanoSphere's market position.
- Determine the company's compliance with regulatory requirements.
- Understand the risks associated with the NanoSphere Delivery System technology.
- Consult with a financial advisor before investing.
- Presence of a functioning website and contact information.
- Patents or intellectual property protection for the NanoSphere Delivery System.
- Partnerships or collaborations with established companies.
- Experienced management team with relevant industry expertise.
- Positive media coverage or industry recognition.
NSHSF Healthcare Stock FAQ
What does NanoSphere Health Sciences Inc. do?
NanoSphere Health Sciences Inc. is a nano-biotechnology company that focuses on developing and commercializing its proprietary NanoSphere Delivery System. This system is designed to enhance the bioavailability and effectiveness of biologically active compounds. The company targets the cannabis, pharmaceutical, and animal health industries, offering improved delivery methods for supplements, nutraceuticals, and over-the-counter medications. NanoSphere aims to differentiate itself through its innovative technology and strategic partnerships, seeking to establish a leading position in the drug delivery market.
What do analysts say about NSHSF stock?
As of 2026-03-17, there is no readily available analyst consensus on NanoSphere Health Sciences Inc. (NSHSF) due to its OTC listing and limited coverage. Key valuation metrics, such as price targets and earnings estimates, are not widely tracked. Investors should conduct their own thorough research and due diligence before considering an investment in NSHSF. Growth considerations include the successful commercialization of the NanoSphere Delivery System, expansion into new markets, and securing regulatory approvals. The speculative nature of the stock warrants caution and a comprehensive understanding of the company's risks and opportunities.
What are the main risks for NSHSF?
The main risks for NanoSphere Health Sciences Inc. include its OTC listing, which entails limited liquidity and transparency. The company faces competition from established drug delivery companies and must navigate regulatory hurdles in the pharmaceutical and cannabis industries. Technological obsolescence is a potential risk, as advancements in drug delivery methods could render the NanoSphere Delivery System less competitive. Additionally, the company's limited financial resources and dependence on partnerships for commercialization pose challenges to its long-term growth and sustainability. Investors should carefully consider these risks before investing in NSHSF.
What are the key factors to evaluate for NSHSF?
NanoSphere Health Sciences Inc. (NSHSF) currently holds an AI score of 48/100, indicating low score. Key strength: Proprietary NanoSphere Delivery System.. Primary risk to monitor: Potential: Competition from established drug delivery companies.. This is not financial advice.
How frequently does NSHSF data refresh on this page?
NSHSF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NSHSF's recent stock price performance?
Recent price movement in NanoSphere Health Sciences Inc. (NSHSF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary NanoSphere Delivery System.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NSHSF overvalued or undervalued right now?
Determining whether NanoSphere Health Sciences Inc. (NSHSF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NSHSF?
Before investing in NanoSphere Health Sciences Inc. (NSHSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- Financial data may not be readily accessible or audited.
- Analyst coverage is limited.